The 36-month beta value for RNXT is at 1.27. Analysts have varying views on the stock, with 2 analysts rating it as a “buy”, 2 rating it as “overweight”, 0 as “hold”, and 0 as “sell”.
The public float for RNXT is 35.32M, and currently, shorts hold a 0.39% of that float. The average trading volume for RNXT on July 04, 2025 was 166.97K shares.
RNXT stock’s latest price update
The stock price of RenovoRx Inc (NASDAQ: RNXT) has jumped by 4.62% compared to previous close of $1.3. Despite this, the company has seen a gain of 0.74% in its stock price over the last five trading days. seekingalpha.com reported 2025-05-15 that RenovoRx, Inc. (NASDAQ:RNXT ) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Valter Pinto – IR Ramtin Agah – Founder and Chief Medical Officer Shaun Bagai – CEO Ronald Kocak – VP Controller and Principal Accounting Officer Conference Call Participants Rafay Khalid – Ascendiant Capital Markets Operator Good afternoon, everyone, and welcome to the RenovoRx Q1 2025 Financial and Operational Highlights Conference Call. All participants will be in a listen-only mode.
RNXT’s Market Performance
RenovoRx Inc (RNXT) has seen a 0.74% rise in stock performance for the week, with a -0.73% decline in the past month and a 36.00% surge in the past quarter. The volatility ratio for the week is 5.33%, and the volatility levels for the past 30 days are at 4.63% for RNXT. The simple moving average for the past 20 days is 0.65% for RNXT’s stock, with a 18.92% simple moving average for the past 200 days.
RNXT Trading at 11.28% from the 50-Day Moving Average
After a stumble in the market that brought RNXT to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -19.52% of loss for the given period.
Volatility was left at 4.63%, however, over the last 30 days, the volatility rate increased by 5.33%, as shares sank -2.16% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading +43.16% upper at present.
During the last 5 trading sessions, RNXT rose by +0.74%, which changed the moving average for the period of 200-days by +20.84% in comparison to the 20-day moving average, which settled at $1.3512. In addition, RenovoRx Inc saw 18.26% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at RNXT starting from Agah Ramtin, who purchase 21,000 shares at the price of $1.40 back on Jun 05 ’25. After this action, Agah Ramtin now owns 734,460 shares of RenovoRx Inc, valued at $29,400 using the latest closing price.
Agah Ramtin, the Chief Medical Officer of RenovoRx Inc, purchase 15,000 shares at $0.90 during a trade that took place back on Apr 15 ’25, which means that Agah Ramtin is holding 1,113,460 shares at $13,500 based on the most recent closing price.
Stock Fundamentals for RNXT
Current profitability levels for the company are sitting at:
- -48.35% for the present operating margin
- 0.61% for the gross margin
The net margin for RenovoRx Inc stands at -42.33%. The total capital return value is set at -0.81%. Equity return is now at value -136.13%, with -97.66% for asset returns.
Based on RenovoRx Inc (RNXT), the company’s capital structure generated 0.01 points at debt to capital in total, while cash flow to debt ratio is standing at -55.39.
Currently, EBITDA for the company is -10.97 million with net debt to EBITDA at 1.24. When we switch over and look at the enterprise to sales, we see a ratio of 147.26. The receivables turnover for the company is 0.99for trailing twelve months and the total asset turnover is 0.01. The liquidity ratio also appears to be rather interesting for investors as it stands at 9.07.
Conclusion
In conclusion, RenovoRx Inc (RNXT) has had a better performance lately. Opinion on the stock among analysts is bullish, with some giving it a “buy” rating and others a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
